Characterization of novel sigma receptor ligands derived from multicomponent reactions as efficacious treatments for neuropathic pain

Authors

Ryosuke Shinouchi, University of Florida
Bengisu Turgutalp, Washington University School of Medicine in St. Louis
Rohini S Ople, Washington University School of Medicine in St. Louis
Shainnel O Eans, University of Florida
Ashai K Williams, University of Florida
Haylee R Hammond, University of Florida
Andras Varadi, Memorial Sloan Kettering Cancer Center
Rebecca Notis Dardashti, Memorial Sloan Kettering Cancer Center
Susruta Majumdar, Washington University School of Medicine in St. Louis
Jay P McLaughlin, University of Florida

Journal

Pharmaceuticals

Publication Date

1-8-2026

Volume

19

Issue

1

First Page

117

Document Type

Open Access Publication

DOI

10.3390/ph19010117

Rights and Permissions

Shinouchi R, Turgutalp B, Ople RS, Eans SO, Williams AK, Hammond HR, Varadi A, Dardashti RN, Majumdar S, McLaughlin JP. Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain. Pharmaceuticals (Basel). 2026 Jan 8;19(1):117. doi: 10.3390/ph19010117 Copyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

Recommended Citation

Shinouchi, Ryosuke; Turgutalp, Bengisu; Ople, Rohini S; Eans, Shainnel O; Williams, Ashai K; Hammond, Haylee R; Varadi, Andras; Dardashti, Rebecca Notis; Majumdar, Susruta; and McLaughlin, Jay P, "Characterization of novel sigma receptor ligands derived from multicomponent reactions as efficacious treatments for neuropathic pain." Pharmaceuticals. 19, 1. 117 (2026).
https://digitalcommons.wustl.edu/oa_4/6206

Additional Links

Supplemental material is available for this article at publisher site.